Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Karin Hohloch"'
Autor:
Katarzyna Szajek, Marie-Elisabeth Kajdi, Valerie A. Luyckx, Thomas Hans Fehr, Ariana Gaspert, Alexia Cusini, Karin Hohloch, Philipp Grosse
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-8 (2021)
Abstract Background Acute kidney injury (AKI) associated with severe coronavirus disease 19 (COVID-19) is common and is a significant predictor of morbidity and mortality, especially when dialysis is required. Case reports and autopsy series have rev
Externí odkaz:
https://doaj.org/article/db4d0d7580b94b81bf1dc2cfcdf38136
Autor:
Karin Hohloch, Marita Ziepert, Lorenz Truemper, Christian Buske, Gerhard Held, Viola Poeschel, Bjoern Chapuy, Bettina Altmann
Publikováno v:
eJHaem, Vol 1, Iss 1, Pp 181-187 (2020)
Abstract Serum albumin a well‐known risk factor predicting outcome in many solid tumors. We explore the role of low serum albumin (≤3.5 g/dL) as an independent risk factor in elderly patients with aggressive B‐cell lymphoma. Outcome of 429 pati
Externí odkaz:
https://doaj.org/article/56e7426ced5f4db7972367ccb707984b
Autor:
Laila König, Martin Dreyling, Jan Dürig, Marianne Engelhard, Karin Hohloch, Andreas Viardot, Mathias Witzens-Harig, Meinhard Kieser, Wolfram Klapper, Christiane Pott, Klaus Herfarth
Publikováno v:
Trials, Vol 20, Iss 1, Pp 1-8 (2019)
Abstract Background Large field irradiation had been standard for early-stage follicular lymphoma (FL) for a long time. Although involved field radiotherapy (IF-RT) was recently favored because of the toxicity of large field irradiation, smaller irra
Externí odkaz:
https://doaj.org/article/4257a87c396748f6be1659d0dc328543
Publikováno v:
BMC Neurology, Vol 19, Iss 1, Pp 1-4 (2019)
Abstract Background Cerebral salt wasting (CSW) is a rare metabolic disorder with severe hyponatremia and volume depletion usually caused by brain injury like trauma, cerebral lesion, tumor or a cerebral hematoma. The renal function is normal with ex
Externí odkaz:
https://doaj.org/article/a002451dd6324c758cd6e69a8c950c00
Autor:
Klaus Herfarth, Peter Borchmann, Sven Schnaidt, Karin Hohloch, Volker Budach, Marianne Engelhard, Andreas Viardot, Rita Engenhart-Cabillic, Ulrich Keller, Gabriele Reinartz, Hans-Theodor Eich, Mathias Witzens-Harig, Clemens F. Hess, Bernd Dörken, Jan Dürig, Thomas Wiegel, Wolfgang Hiddemann, Eva Hoster, Christiane Pott, Martin Dreyling
Publikováno v:
HemaSphere, Vol 2, Iss 6 (2018)
Abstract. The MabThera and Involved field Radiotherapy study investigated efficacy and safety of involved field (IF) radiotherapy in combination with the anti-CD20 antibody Rituximab for early-stage follicular lymphoma (FL) in a prospective, single-a
Externí odkaz:
https://doaj.org/article/3b975c9773894904a30ae659e98cefb3
Publikováno v:
InFo Hämatologie + Onkologie. 26:10-20
Autor:
Karin Hohloch
Publikováno v:
InFo Hämatologie + Onkologie. 26:3-3
Autor:
Alexia Cusini, Karin Hohloch, Philipp Grosse, Katarzyna Szajek, Marie-Elisabeth Kajdi, Ariana Gaspert, Thomas Fehr, Valerie A. Luyckx
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-8 (2021)
BMC Nephrology
BMC Nephrology
Background Acute kidney injury (AKI) associated with severe coronavirus disease 19 (COVID-19) is common and is a significant predictor of morbidity and mortality, especially when dialysis is required. Case reports and autopsy series have revealed tha
Autor:
Lorenz Trümper, Florian Zettl, Marita Ziepert, Norbert Schmitz, Karin Hohloch, Bettina Altmann, Markus Loeffler, Bertram Glass, Viola Pöschel, Gerhard Held, Gerald Wulf, Samira Zeynalova
Publikováno v:
Annals of Hematology
In elderly patients (pts) with aggressive B cell lymphoma (aNHL), curative treatment often cannot be administered because of comorbidities and tolerability. We analyzed the influence of age in pts > 60 years receiving the R-CHOP-14 regimen within dif
Autor:
Anastasios Stathis, Ulrich Mey, Sämi Schär, Felicitas Hitz, Christiane Pott, Nicolas Mach, Fatime Krasniqi, Urban Novak, Christian Schmidt, Karin Hohloch, Dirk Lars Kienle, Dagmar Hess, Alden A. Moccia, Michael Unterhalt, Katrin Eckhardt, Stefanie Hayoz, Gabriela Forestieri, Davide Rossi, Stefan Dirnhofer, Luca Ceriani, Giulio Sartori, Francesco Bertoni, Christian Buske, Emanuele Zucca, Wolfgang Hiddemann
This phase 1 study evaluated safety, tolerability, and preliminary efficacy of obinutuzumab in combination with venetoclax in patients with previously untreated grade 1-3a follicular lymphoma in need of systemic therapy. Two DLs of venetoclax were ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd4f5ea053fe49750db60517bc3aca74